Kota Tsuruya

787 total citations
46 papers, 408 citations indexed

About

Kota Tsuruya is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kota Tsuruya has authored 46 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 18 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Kota Tsuruya's work include Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Pediatric Hepatobiliary Diseases and Treatments (8 papers). Kota Tsuruya is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Pediatric Hepatobiliary Diseases and Treatments (8 papers). Kota Tsuruya collaborates with scholars based in Japan and Spain. Kota Tsuruya's co-authors include Tatehiro Kagawa, Yoshitaka Arase, Shunji Hirose, Yutaka Inagaki, Akihide Kamiya, Koichi Shiraishi, Tetsuya Mine, Yasuhiro Nakano, Hideaki Sumiyoshi and Hiromi Chikada and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Kota Tsuruya

39 papers receiving 401 citations

Peers

Countries citing papers authored by Kota Tsuruya

Since Specialization

Citations

This map shows the geographic impact of Kota Tsuruya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kota Tsuruya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kota Tsuruya more than expected).

Fields of papers citing papers by Kota Tsuruya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kota Tsuruya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kota Tsuruya. The network helps show where Kota Tsuruya may publish in the future.

Co-authorship network of co-authors of Kota Tsuruya

This figure shows the co-authorship network connecting the top 25 collaborators of Kota Tsuruya. A scholar is included among the top collaborators of Kota Tsuruya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kota Tsuruya. Kota Tsuruya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune‐related adverse event detection in liver cancer patients treated with immune checkpoint inhibitors: Nationwide exploratory survey in Japan 2024 ·Hepatology Research ·(unknown), (unknown), Mamoru Sakakibara, (unknown), (unknown), (unknown), Koichi Shiraishi, Yoshitaka Arase, Kota Tsuruya, Shunji Hirose, (unknown), Tatehiro Kagawa	1
2	RECAM‐J 2023—Validation and development of the Japanese version of RECAM for the diagnosis of drug‐induced liver injury 2024 ·Hepatology Research ·Atsushi Tanaka, Keiji Tsuji, Yasuyuki Komiyama, Kota Tsuruya, Keisuke Kakisaka, Akemi Tsutsui, Keiko Ichimoto, Masayuki Ueno, (unknown), Hiroteru Kamimura, Atsushi Takai, Noriyo Yamashiki, Takanori Ito, Masaaki Watanabe, Masanori Abe, Kenichi Harada, Tatehiro Kagawa	7
3	Progression pattern and post‐progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma 2024 ·Liver International ·Satoshi Kobayashi, Taito Fukushima, Makoto Ueno, Makoto Chuma, Kazushi Numata, Kota Tsuruya, Yoshitaka Arase, Shunji Hirose, (unknown), Nobuhiro Hattori, Tsunamasa Watanabe, Kotaro Matsunaga, Haruki Uojima, Hisashi Hidaka, Chika Kusano, Manabu Morimoto, Shin Maeda	0
4	Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD 2024 ·Scientific Reports ·Jin Imai, Shinji Takashimizu, (unknown), (unknown), (unknown), (unknown), Kota Tsuruya, Yoshitaka Arase, (unknown), Noriaki Kishimoto, Chizumi Yamada, Nagamu Inoue, Kengo Moriyama, Akiyasu Baba, Hidekazu Suzuki, Tatehiro Kagawa, Yasuhiro Nishizaki	1
5	First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan 2023 ·BMJ Open Gastroenterology ·Kota Tsuruya, (unknown), (unknown), Shun Ono, (unknown), Takuya Hara, (unknown), Yoshitaka Arase, Shunji Hirose, Koichi Shiraishi, Tatehiro Kagawa	0
6	Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting 2021 ·JGH Open ·Taito Fukushima, Manabu Morimoto, Makoto Ueno, (unknown), Haruki Uojima, Hisashi Hidaka, Makoto Chuma, Kazushi Numata, Kota Tsuruya, Shunji Hirose, (unknown), Nobuhiro Hattori, Tsunamasa Watanabe, Kotaro Matsunaga, Kouji Yamamoto, Katsuaki Tanaka, Shin Maeda	5
7	Kruppel-like factor 15 induces the development of mature hepatocyte-like cells from hepatoblasts 2021 ·Scientific Reports ·(unknown), Kota Tsuruya, (unknown), Tatehiro Kagawa, Yutaka Inagaki, Akihide Kamiya	10
8	Influence of arm position on proton density fat fraction in the liver using chemical shift-encoded magnetic resonance imaging 2021 ·Magnetic Resonance Imaging ·(unknown), (unknown), Tatsuya Hayashi, Kota Tsuruya, Tetsu Niwa	0
9	Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients 2020 ·PLoS ONE ·Shunji Hirose, Koshi Matsumoto, Masayuki Tatemichi, Kota Tsuruya, (unknown), Yoshitaka Arase, Koichi Shiraishi, Michiko Suzuki, (unknown), Tatehiro Kagawa	31
10	Hypothyroidism Is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy 2020 ·Cancers ·(unknown), (unknown), (unknown), Kota Fukai, Koichi Shiraishi, Shunji Hirose, Kota Tsuruya, Yoshitaka Arase, (unknown), Tatehiro Kagawa	15
11	Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus 2019 ·Clinical Drug Investigation ·Yoshitaka Arase, Koichi Shiraishi, (unknown), Hirohiko Sato, (unknown), Kota Tsuruya, Shunji Hirose, Ryuzo Deguchi, Masao Toyoda, Tetsuya Mine, Tatehiro Kagawa	22
12	Rapid Regression of B-Cell Non-Hodgkin’s Lymphoma after Eradication of Hepatitis C Virus by Direct Antiviral Agents 2019 ·Case Reports in Gastroenterology ·Shunji Hirose, (unknown), Kota Tsuruya, Yoshiaki Ogawa, Masashi Miyaoka, Tatehiro Kagawa	4
13	Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites 2018 ·Clinical Drug Investigation ·Yoshitaka Arase, Tatehiro Kagawa, Kota Tsuruya, Hirohiko Sato, (unknown), (unknown), Shunji Hirose, Ryuzo Deguchi, Koichi Shiraishi, Tetsuya Mine	10
14	An in vitro model of polycystic liver disease using genome-edited human inducible pluripotent stem cells 2018 ·Stem Cell Research ·Akihide Kamiya, Hiromi Chikada, (unknown), (unknown), Kota Tsuruya, Tatehiro Kagawa, Yutaka Inagaki	7
15	Foetal hepatic progenitor cells assume a cholangiocytic cell phenotype during two-dimensional pre-culture 2016 ·Scientific Reports ·(unknown), Hiromi Chikada, Kota Tsuruya, (unknown), Tatehiro Kagawa, Yutaka Inagaki, (unknown), Akihide Kamiya	13
16	Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B 2016 ·BMC Gastroenterology ·(unknown), Tatehiro Kagawa, Shunji Hirose, Yoshitaka Arase, Kota Tsuruya, (unknown), Koichi Shiraishi, Tetsuya Mine	15
17	Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment 2016 ·BMC Cancer ·(unknown), Tatehiro Kagawa, (unknown), Koichi Shiraishi, Shunji Hirose, Yoshitaka Arase, Kota Tsuruya, (unknown), Tetsuya Mine	17
18	A Paracrine Mechanism Accelerating Expansion of Human Induced Pluripotent Stem Cell-Derived Hepatic Progenitor-Like Cells 2015 ·Stem Cells and Development ·Kota Tsuruya, Hiromi Chikada, (unknown), (unknown), Tatehiro Kagawa, Yutaka Inagaki, Tetsuya Mine, Akihide Kamiya	11
19	Malignant peritoneal mesothelioma presenting umbilical hernia and Sister Mary Joseph’s nodule 2013 ·World Journal of Gastrointestinal Endoscopy ·Kota Tsuruya	3
20	Acute portal vein thrombosis due to chronic relapsing pancreatitis: a fistula between a pancreatic pseudocyst and the splenic vein 2013 ·Clinical Journal of Gastroenterology ·Masahiro Kikuchi, Yasuhiro Nishizaki, Kota Tsuruya, (unknown), (unknown), (unknown), (unknown), Jun Aoki, (unknown), Jun Koizumi, Yoshitaka Arase, Koichi Shiraishi, Masashi Matsushima, Tetsuya Mine	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact